Hongbing Zhang
Accenture (Switzerland)(CH)Tianjin University of Technology(CN)China Three Gorges University(CN)Tianjin University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Chang'an University(CN)Peking Union Medical College Hospital(CN)Tianjin Medical University General Hospital(CN)Tianjin Medical University Cancer Institute and Hospital(CN)Southwest Medical University(CN)Soochow University(CN)Eureka Therapeutics (United States)(US)General Hospital of Guangzhou Military Command(CN)Beijing Luhe Hospital Affiliated to Capital Medical University(CN)Jiangsu Provincial Center for Disease Control and Prevention(CN)Cancer Research Center(US)Hangzhou Wanxiang Polytechnic(CN)First Hospital of China Medical University(CN)First Affiliated Hospital of Soochow University(CN)First Hospital of Lanzhou University(CN)Hebei University(CN)Lanzhou University(CN)Southeast University(CN)China Medical University(CN)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Tuberous Sclerosis Complex Research, Cancer, Hypoxia, and Metabolism, MicroRNA in disease regulation, Epigenetics and DNA Methylation
Most-Cited Works
- → Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development(1996)979 cited
- → Regulation of cellular growth by the Drosophila target of rapamycin dTOR(2000)626 cited
- → Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth(2011)571 cited
- → Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR(2003)497 cited
- → PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR(2007)380 cited
- → Regulation of Autophagy by mTOR Signaling Pathway(2019)350 cited